Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial
- Resource Type
- Article
- Source
- In
Cancer Pathogenesis and Therapy January 2024 2(1):31-37 - Subject
- Language
- ISSN
- 2949-7132